MANDELL JAMES sold 50.0% of their position (1K shares) of BLUEBIRD BIO, INC. on the open market
Open‑market sale worth $150.8K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 9/12/2018ACC: 0001209191-18-050625
-1K
Net shares
Net seller
$150.8K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
1K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−432.00
Price / share
$150.06
Trade value
$64.83K
% of position
21.6%
9/10/2018
2K→1.57K
Common Stock
Direct
Shares
−501.00
Price / share
$151.22
Trade value
$75.76K
% of position
32.0%
9/10/2018
1.57K→1.07K
Common Stock
Direct
Shares
−67.00
Price / share
$152.00
Trade value
$10.18K
% of position
6.3%
9/10/2018
1.07K→1K
Total
Net shares
−1K
Net value
-$150.77K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/10/2018 | S · Sale | −432.00 | $150.06 | $64.83K | 21.6% | 2K | 1.57K |
| Common Stock Direct | 9/10/2018 | S · Sale | −501.00 | $151.22 | $75.76K | 32.0% | 1.57K | 1.07K |
| Common Stock Direct | 9/10/2018 | S · Sale | −67.00 | $152.00 | $10.18K | 6.3% | 1.07K | 1K |
| Total | −1K | -$150.77K | ||||||
Derivative Transactions0
No derivative transactions reported